Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

Slides:

Advertisements

Similar presentations

Stephen P. McDonald, Graeme R. Russ Kidney International

Advertisements

Volume 82, Issue 12, Pages (December 2012)

First-year death rates by modality figure 8

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Treatment of acute renal failure

Mortality rates in incident ESRD patients figure 9

Mitchell H. Rosner, W. Kline Bolton Kidney International

Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients Jiacong Luo, MD, MS, MPH, Donna E.

In Reply to ‘The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis’ Emily J. See, MBBS, David W. Johnson, PhD, Yeoungjee.

End-stage renal disease in developing countries

Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery Wolfgang C. Winkelmayer, Robert J. Glynn,

Volume 83, Issue 3, Pages (March 2013)

Volume 63, Issue 1, Pages (January 2003)

Volume 61, Issue 2, Pages (February 2002)

Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Volume 64, Issue 3, Pages (September 2003)

John P. Middleton, Patrick H. Pun Kidney International

IP155. Transplant Wait Listing Attenuates the Association Between Hemodialysis Access and Mortality Courtenay Holscher, Sunjae Bae, Christine Haugen,

Type of vascular access and mortality in U.S. hemodialysis patients

Syncope: Outcomes and Conditions Associated with Hospitalization

Volume 82, Issue 12, Pages (December 2012)

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Molly E. Waring, PhD, Jane S

Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis Connie M. Rhee, MD, MSc, Csaba P. Kovesdy,

Volume 79, Pages S9-S13 (April 2011)

Homocysteine and risk in end-stage renal disease: a matter of context

Volume 68, Issue 6, Pages (December 2005)

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

Volume 76, Issue 10, Pages (November 2009)

Volume 80, Issue 9, Pages (November 2011)

Volume 84, Issue 5, Pages (November 2013)

Volume 63, Issue 2, Pages (February 2003)

Volume 86, Issue 4, Pages (October 2014)

Survival advantage in Asian American end-stage renal disease patients1

Volume 68, Issue 5, Pages (November 2005)

Volume 70, Issue 11, Pages (December 2006)

Volume 77, Issue 7, Pages (April 2010)

Treatment of acute renal failure

Stephen P. McDonald Kidney International Supplements

U-shaped effect of eGFR and mortality

Body size and outcomes on peritoneal dialysis in the United States

Volume 70, Issue 12, Pages (December 2006)

Volume 83, Issue 2, Pages (February 2013)

Alternate-day dialysis may be needed for hemodialysis patients

Methods for guideline development

Volume 76, Issue 8, Pages (October 2009)

Volume 80, Issue 6, Pages (September 2011)

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease C.P. Kovesdy, S. Ahmadzadeh,

David A. Goodkin, MD, Eric W

Volume 84, Issue 4, Pages (October 2013)

Volume 72, Issue 4, Pages (August 2007)

Volume 80, Issue 12, Pages (December 2011)

Stephen P. McDonald, Graeme R. Russ Kidney International

Volume 77, Issue 12, Pages (June 2010)

Volume 64, Issue 2, Pages (August 2003)

Volume 82, Issue 3, Pages (August 2012)

Volume 61, Issue 1, Pages (January 2002)

Volume 80, Issue 10, Pages (November 2011)

Michael R. Lattanzio, Matthew R. Weir Kidney International

Charles A. Herzog Kidney International

Volume 53, Issue 5, Pages (May 1998)

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1 William M.

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes Steven M. Brunelli, Ravi Thadhani,

Volume 61, Issue 2, Pages (February 2002)

The International Pediatric Peritonitis Registry: Starting to walk

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R. Murthy, Donald A. Molony Kidney International Volume 65, Issue 6, Pages 2398-2408 (June 2004) DOI: 10.1111/j.1523-1755.2004.00654.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (<20.9 kg/m2). All models adjusted for age at study start, gender, race, hypertension, coronary artery disease, cardiac arrest/arrhythmia, peripheral vascular and cerebrovascular disease, congestive heart failure, tobacco use, chronic lung disease, AIDS, neoplasm, alcohol dependence, serum albumin, hematocrit, estimated glomerular filtration rate, functional status (inability to walk and transfer), and pre-ESRD erythropoietin use. Kidney International 2004 65, 2398-2408DOI: (10.1111/j.1523-1755.2004.00654.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (20.9–23.5 kg/m2). Kidney International 2004 65, 2398-2408DOI: (10.1111/j.1523-1755.2004.00654.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (23.5–26.1 kg/m2). Kidney International 2004 65, 2398-2408DOI: (10.1111/j.1523-1755.2004.00654.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (26.1–30.0 kg/m2). Kidney International 2004 65, 2398-2408DOI: (10.1111/j.1523-1755.2004.00654.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Adjusted Cox survival curves for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis versus hemodialysis stratified by body mass index (BMI) quintile (>30.0 kg/m2). Kidney International 2004 65, 2398-2408DOI: (10.1111/j.1523-1755.2004.00654.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 6 Relative risk of death by body mass index (BMI) quintile for new end-stage renal disease (ESRD) patients treated with hemodialysis. All models adjusted for age at study start, gender, race, hypertension, coronary artery disease, cardiac arrest/arrhythmia, peripheral vascular and cerebrovascular disease, congestive heart failure, tobacco use, chronic lung disease, AIDS, neoplasm, alcohol dependence, serum albumin, hematocrit, estimated glomerular filtration rate, functional status (inability to walk and transfer), and pre-ESRD erythropoietin use. *P < 0.05; **P < 0.01; ***P < 0.001 compared to a relative risk of 1.00. Reference BMI 23.5–26.1 kg/m2. Kidney International 2004 65, 2398-2408DOI: (10.1111/j.1523-1755.2004.00654.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 7 Relative risk of death by body mass index (BMI) quintile for new end-stage renal disease (ESRD) patients treated with peritoneal dialysis. All models adjusted for age at study start, gender, race, hypertension, coronary artery disease, cardiac arrest/arrhythmia, peripheral vascular and cerebrovascular disease, congestive heart failure, tobacco use, chronic lung disease, AIDS, neoplasm, alcohol dependence, serum albumin, hematocrit, estimated glomerular filtration rate, functional status (inability to walk and transfer), and pre-ESRD erythropoietin use. *P < 0.05; **P < 0.01; ***P < 0.001 compared to a relative risk of 1.00. Reference BMI 23.5–26.1 kg/m2. Kidney International 2004 65, 2398-2408DOI: (10.1111/j.1523-1755.2004.00654.x) Copyright © 2004 International Society of Nephrology Terms and Conditions